Legend Biotech
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · New Jersey, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2101 Cottontail Ln, Somerset, New Jersey...Phone Number
(732) 317-5050Website
www.legendbiotech.comRevenue
$627.2 MillionStock Symbol
LEGNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
7
6
1
2
1
1
About Legend Biotech
Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications.Explore more
Legend Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Legend Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Legend Biotech had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Legend Biotech has new funding data
Legend Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Legend Biotech
Check out if Legend Biotech is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Legend Biotech recently announced quarterly report
Check if Legend Biotech has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Legend Biotech launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Legend Biotech
Compare insights from companies similar to Legend Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Legend Biotech
$627.2M
1K - 5K
Public
$574.5M
2014
KC
Kiran ChereddyDirector, Project Management & Plant Chief of Staff
$675.1M
1K - 5K
Private
$225M
2009
KD
Kristen DravesDirector, Head of Business Strategy and Operations. Chief of Staff
Company Profile Activity
Activity Insights
Legend Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Legend Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Legend Biotech.
Legend Biotech financials insights
Gather financial insights about Legend Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Series A
$150.5M
Stock Offering
$424M
Legend Biotech Tech Stack
A closer look at the technologies used by Legend Biotech
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Legend Biotech News & Media
Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026
BRIDGEWATER, N.J., June 01, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech or the Company), a global leader in cell therapy, today announced first-in-human clinical data for LB2102, its investigational DLL3-targeted CAR-T cell therapy for patients with relapsed or refractory small cell lung cancer (SCLC) or large-cell neuroendocrine carcinoma (LCNEC). The data demonstrate early evidence of clinical activity and a manageable safety profile. At higher dose levelLegend Biotech Corporation (LEGN) Shareholder/Analyst Call Transcript
Legend Biotech Corporation (LEGN) Shareholder/Analyst Call May 31, 2026 7:15 PM EDTCompany ParticipantsYing Huang - CEO & DirectorAlan Bash - President...Legend Biotech Conference Spotlights CARVYKTI’s Curative Potential, Earlier Use
Legend Biotech (NASDAQ:LEGN) used an investor and analyst event to highlight long-term data and physician perspectives supporting broader use of CARVYKTI, its BCMA-directed CAR T-cell therapy for multiple myeloma developed, manufactured and co-promoted with Johnson & Johnson. Chief Executive OfLegend Biotech Announces Presentations at ASCO 2026
SOMERSET, N.J., May 21, 2026 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech or the Company), a global leader in cell therapy, today announced multiple presentations at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, including a rapid oral presentation highlighting preliminary Phase 1 data for LB2102, its investigational DLL3-targeted CAR-T therapy for relapsed or refractory small-cell lung cancer (SCLC) and large-cell neuroendocrine carcinoma
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Legend Biotech
Sign Up For FreeTo access detailed company insights
Legend Biotech is a global clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications.... Read More
